Skip to content
HowShorted

Avid Bioservices, Inc. short interest in 2021

In 2021, Avid Bioservices, Inc.'s disclosed short interest ran from 3.81% of shares outstanding on 15 Jan 2021 to 9.51% on 31 Dec 2021, a change of +5.70 percentage points. The year's high was 10.12% on 15 Dec 2021 and its low 3.55% on 12 Feb 2021, averaging 7.06% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.46 days on 30 Jul 2021. Full history: Avid Bioservices, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for Avid Bioservices, Inc. in 2021

2021 in figures

Start of year
3.81% (15 Jan 2021)
End of year
9.51% (31 Dec 2021)
Change
+5.70 pp
High
10.12% (15 Dec 2021)
Low
3.55% (12 Feb 2021)
Average
7.06%
Highest days to cover
12.46 (30 Jul 2021)
SEC filings marked
8

Every report in 2021

Avid Bioservices, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20213.81%4.36
29 Jan 20213.89%4.78
12 Feb 20213.55%2.88
26 Feb 20213.69%4.02
15 Mar 20216.27%2.4210-Q filed, results (8-K)
31 Mar 20215.97%5.70
15 Apr 20216.12%7.89
30 Apr 20216.32%11.56
14 May 20216.56%10.85
28 May 20216.22%7.48
15 Jun 20216.42%7.62
30 Jun 20217.94%4.8810-K filed, results (8-K)
15 Jul 20218.01%7.71
30 Jul 20217.84%12.46
13 Aug 20217.37%7.77
31 Aug 20217.49%12.11
15 Sep 20217.51%6.9610-Q filed, results (8-K)
30 Sep 20218.35%8.97
15 Oct 20218.15%9.56
29 Oct 20218.74%2.03
15 Nov 202110.06%8.35
30 Nov 20219.48%9.08
15 Dec 202110.12%8.0210-Q filed, results (8-K)
31 Dec 20219.51%8.15

See also: Avid Bioservices, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.